You are here

P&T News

October 21

Reference pricing aims to cut costs
Safety involves three key principles
Experts anticipate launch of first therapies for geographic atrophy

October 20

Disease ignored by public, neglected by doctors, experts say
Flexible custom mask covers hollow eye socket at lower cost
Morphine/naltrexone combo expected to reduce oral abuse when crushed

October 17

Top-line results released in NIH-funded comparison of effectiveness
British research focused on the role of enzymes in bacteria
Progressive scarring of lungs leaves patients short of breath
Studies will prepare vaccine candidate for clinical trials

October 16

Medications and nonpharmacologic recommendations graded
Longer period might be needed to prevent virus spread, expert says
New data support efficacy of chimeric antigen receptor therapy

October 15

Replaceable device allows urination without catheterization
Additional exposures were expected, agency says
Novel antipsychotic and improved rescue therapy take center stage by 2023

October 14

Soliris takes the prize at nearly $537,000 per year
Modified sulfonylurea stimulates insulin release
Drug’s effect on weight change, sexual function similar to that of placebo
Approval decision expected in April 2015

October 13

Drug’s effect on weight change, sexual function similar to that of placebo

October 13

Harvard discovery could help prevent clotting and infections
Certain patients with genotype-1 infections need just 8 weeks of treatment
Living-cell bioformulation fails to provide significant improvement
Health care worker is first to develop disease in U.S.

October 12

Living-cell bioformulation fails to provide significant improvement
Health care worker is first to develop disease in U.S.
Harvard discovery could help prevent clotting and infections

October 10

Author identifies financial constraints on antibiotic research
Array of genetic defects thwart targeted treatments

October 8

Oral nucleotide analog demonstrates antiviral activity

Pages

P&T TV

From Sovaldi to Ebola: A Wide-ranging Interview with Dr. David Nash

A leading authority on population health, Dr. David Nash is optimistic about the future of disruptive innovation to improve healthcare in the U.S. The interview was conducted by P&T Editor Sonja Sherritze.

Interview

Meetings

Nashville, TN
November 3 to November 4
Brussels, Belgium
November 12 to November 14

Free App

MediMedia App IconManaged Care, and P&T are available for free on multiple mobile platforms and devices. For Apple and iOS devices, visit the Apple Store and download the free digital application for Managed Care and P&T. Search for "Managed Care," "Pharmacy and Therapeutics," or "MediMedia."

Users of Android, Blackberry, Nook, and Kindle can view the mobile version on their respective devices by visiting these Web sites: Managed Care and P&T.